Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial: research results and clinical value.
10.3760/cma.j.issn.2095-4352.2019.10.004
- Author:
EDITORIAL BOARD OF CHINESE CRITICAL CARE MEDICINE
- Publication Type:Randomized Controlled Trial
- MeSH:
Community-Acquired Infections/drug therapy*;
Critical Illness;
Drugs, Chinese Herbal/therapeutic use*;
Humans;
Pneumonia/drug therapy*
- From:
Chinese Critical Care Medicine
2019;31(10):1199-1203
- CountryChina
- Language:Chinese
-
Abstract:
This article is based on the research paper named Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial which was published in Critical Care Medicine (CCM), introducing its study results and relevant clinical value. Moreover, we attached two peer experts' comments on this study for the readers' reference.
